![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 17")
LINC01996 suppresses non-small cell lung cancer proliferation and metastasis by orchestrating the miR-12115/CNRIP1/Ras signaling axis.
Comments Off on LINC01996 suppresses non-small cell lung cancer proliferation and metastasis by orchestrating the miR-12115/CNRIP1/Ras signaling axis.
April 29, 2026
Preclinical research identifies CNRIP1 cannabinoid receptor protein as a tumor suppressor in lung cancer models. This laboratory study reveals new mechanisms of endocannabinoid system proteins in cancer biology, though clinical applications remain…
Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.
Comments Off on Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.
April 28, 2026
Researchers developed HKC54, a selective TRPV2 antagonist that inhibits cancer cell migration in laboratory studies. This TRPV2 antagonist cancer cell migration research represents early-stage drug development that could eventually lead to new…